Similar articles

• Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine.

  Tsai CC, Follis KE, Sabo A, Beck TW, Grant RF, Bischofberger N, Benveniste RE, Black R. Tsai CC, et al. Science. 1995 Nov 17;270(5239):1197-9. doi: 10.1126/science.270.5239.1197. Science. 1995. PMID: 7502044
• Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection.

  Tsai CC, Emau P, Sun JC, Beck TW, Tran CA, Follis KE, Bischofberger N, Morton WR. Tsai CC, et al. J Med Primatol. 2000 Aug;29(3-4):248-58. doi: 10.1034/j.1600-0684.2000.290318.x. J Med Primatol. 2000. PMID: 11085587
• Drug prevents SIV infection.

  McCarthy M. McCarthy M. Lancet. 1995 Dec 2;346(8988):1482. doi: 10.1016/s0140-6736(95)92492-2. Lancet. 1995. PMID: 7491000 No abstract available.
• Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus.

  Benhamou Y, Poynard T. Benhamou Y, et al. J Hepatol. 2003;39 Suppl 1:S194-9. doi: 10.1016/s0168-8278(03)00321-0. J Hepatol. 2003. PMID: 14708703 Review. No abstract available.
• The use of tenofovir disoproxil fumarate for the treatment of nucleoside-resistant HIV-1.

  McColl DJ, Miller MD. McColl DJ, et al. J Antimicrob Chemother. 2003 Feb;51(2):219-23. doi: 10.1093/jac/dkg109. J Antimicrob Chemother. 2003. PMID: 12562684 Review. No abstract available.